Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bast

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|August 1, 1994
Cytogenetic abnormalities in B-immunoblastic lymphomaM B Nashelsky, M M Hess, D D Weisenburger, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profileH Jacobs, G H Koek, R Peters, et al.
Archives of Toxicology|March 26, 2014
Apoptotic, inflammatory, and fibrogenic effects of two different types of multi-walled carbon nanotubes in mouse lungD van Berlo, V Wilhelmi, A W Boots, et al.
British Journal of Cancer|December 4, 2003
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitroM A I Abou-El-Hassan, M J W E Rabelink, W J F van der Vijgh, et al.
Journal of Perinatal Medicine|January 1, 1997
Decreased first trimester uric acid production in future preeclamptic patientsC L de Jong, K M Paarlberg, H P van Geijn, et al.
Toxicology|December 14, 2004
Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cellsG Michels, W Wätjen, P Niering, et al.
Cancer Research|October 1, 1993
Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c miceS A van Acker, E E Voest, D B Beems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphomaY Yan, W C Chan, D D Weisenburger, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 3, 1998
Maternal and fetal plasma concentrations of endothelin, lipidhydroperoxides, glutathione peroxidase and fibronectin in relation to abnormal umbilical artery velocimetryV H Karsdorp, G A Dekker, A Bast, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of lipid peroxidation mediated by indolizinesA I Nasir, L L Gundersen, F Rise, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|August 1, 1994
Cytogenetic abnormalities in B-immunoblastic lymphomaM B Nashelsky, M M Hess, D D Weisenburger, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profileH Jacobs, G H Koek, R Peters, et al.
Archives of Toxicology|March 26, 2014
Apoptotic, inflammatory, and fibrogenic effects of two different types of multi-walled carbon nanotubes in mouse lungD van Berlo, V Wilhelmi, A W Boots, et al.
British Journal of Cancer|December 4, 2003
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitroM A I Abou-El-Hassan, M J W E Rabelink, W J F van der Vijgh, et al.
Journal of Perinatal Medicine|January 1, 1997
Decreased first trimester uric acid production in future preeclamptic patientsC L de Jong, K M Paarlberg, H P van Geijn, et al.
Toxicology|December 14, 2004
Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cellsG Michels, W Wätjen, P Niering, et al.
Cancer Research|October 1, 1993
Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c miceS A van Acker, E E Voest, D B Beems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphomaY Yan, W C Chan, D D Weisenburger, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 3, 1998
Maternal and fetal plasma concentrations of endothelin, lipidhydroperoxides, glutathione peroxidase and fibronectin in relation to abnormal umbilical artery velocimetryV H Karsdorp, G A Dekker, A Bast, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of lipid peroxidation mediated by indolizinesA I Nasir, L L Gundersen, F Rise, et al.
Pageof 30